Short answer · Medically reviewed summary · Last updated: 2023-07-13
Rabson-Mendenhall Syndrome (RMS) is an extremely rare genetic disorder characterized by severe insulin resistance. Due to its rarity, the prevalence of RMS is difficult to determine precisely.
What is the prevalence of Rabson-Mendenhall Syndrome?
Prevalence of Rabson-Mendenhall Syndrome: how many people are affected worldwide, differences by sex and region, with sources.
Rabson-Mendenhall Syndrome (RMS) is an extremely rare genetic disorder characterized by severe insulin resistance. Due to its rarity, the prevalence of RMS is difficult to determine precisely. However, it is estimated to affect fewer than 1 in 1,000,000 individuals worldwide.
RMS is inherited in an autosomal recessive manner, meaning that both parents must carry a copy of the mutated gene for their child to be affected. The syndrome is caused by mutations in the insulin receptor gene (INSR), which leads to impaired insulin signaling and subsequent insulin resistance.
Individuals with RMS typically present with distinct physical features, such as acanthosis nigricans (dark, thickened skin), hypertrichosis (excessive hair growth), and dental abnormalities. They also experience severe insulin resistance, resulting in early-onset diabetes and various metabolic abnormalities.
Due to the rarity of RMS, diagnosis can be challenging and often requires genetic testing to confirm the presence of INSR mutations. Management of the syndrome involves a multidisciplinary approach, including close monitoring of blood glucose levels, insulin therapy, and addressing associated health issues.
Although Rabson-Mendenhall Syndrome is an extremely rare disorder, understanding its prevalence and characteristics is crucial for early diagnosis and appropriate management of affected individuals.
